⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL640792 | 1.00 | — | — | |
| SCHEMBL640791 | 1.00 | — | — | |
| SCHEMBL18074135 | 0.75 | — | — | |
| SCHEMBL18074131 | 0.75 | — | — | |
| SCHEMBL13762165 | 0.72 | — | — | |
| SCHEMBL13762169 | 0.72 | — | — | |
| SCHEMBL5028673 | 0.72 | — | — | |
| SCHEMBL12660411 | 0.69 | KDM4E (0.31) | — | |
| SCHEMBL31293584 | 0.69 | — | — | |
| SCHEMBL18911283 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382307-A1 | IMPROVED METHODS FOR PREPARING N-METHYL ALANINE ESTERS OF MAYTANSINOL | IMMUNOGEN, INC. | 2025-12-18 | — | — | US | disclosed |
| EP-4587445-A1 | IMPROVED METHODS FOR PREPARING N-METHYL ALANINE ESTERS OF MAYTANSINOL | ImmunoGen, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2024059267-A1 | IMPROVED METHODS FOR PREPARING N-METHYL ALANINE ESTERS OF MAYTANSINOL | IMMUNOGEN, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-2152680-B1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI SA (FR) | 2015-06-24 | — | — | EP | disclosed |
| EP-2152680-B1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI SA (FR) | 2015-06-24 | — | — | EP | disclosed |
| US-20120215007-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI (FR) | 2012-08-23 | — | — | US | disclosed |
| US-20120215007-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI (FR) | 2012-08-23 | — | — | US | disclosed |
| US-20120215007-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI (FR) | 2012-08-23 | — | — | US | disclosed |
| US-8119813-B2 | Method for preparing enantiomerically enriched N-carboxyanhydride | SANOFI-AVENTIS (FR) | 2012-02-21 | — | — | US | disclosed |
| US-8119813-B2 | Method for preparing enantiomerically enriched N-carboxyanhydride | SANOFI-AVENTIS (FR) | 2012-02-21 | — | — | US | disclosed |
| US-8119813-B2 | Method for preparing enantiomerically enriched N-carboxyanhydride | SANOFI-AVENTIS (FR) | 2012-02-21 | — | — | US | disclosed |
| EP-1838715-B1 | METHOD FOR THE PREPARATION OF MAYTANSINOID ESTERS | IMMUNOGEN INC (US) | 2010-10-27 | — | — | EP | disclosed |
| US-20100113797-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI-AVENTIS (FR) | 2010-05-06 | — | — | US | disclosed |
| US-20100113797-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI-AVENTIS (FR) | 2010-05-06 | — | — | US | disclosed |
| US-20100113797-A1 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI-AVENTIS (FR) | 2010-05-06 | — | — | US | disclosed |
| EP-2152680-A2 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED<I>N</I>-CARBOXYANHYDRIDE | Sanofi-Aventis (FR) | 2010-02-17 | — | — | EP | disclosed |
| WO-2009004141-A2 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI-AVENTIS (FR) | 2009-01-08 | — | — | WO | disclosed |
| WO-2009004141-A2 | METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE | SANOFI-AVENTIS (FR) | 2009-01-08 | — | — | WO | disclosed |
| US-7301019-B2 | Method for the preparation of maytansinoid esters | IMMUNOGEN, INC. (US) | 2007-11-27 | — | — | US | disclosed |
| US-7301019-B2 | Method for the preparation of maytansinoid esters | IMMUNOGEN, INC. (US) | 2007-11-27 | — | — | US | disclosed |